Replies to post #20269 on Synaptogenix Inc (SNPX)

[InTheTrenches]

Good for BIIB/ESALY.

Their trial was in early AD, which might be the best population for the Amyloid hypothesis to work.

[Cyosol]

Slows down cognitive decline by 27% after 18 months and 21.3% of those who received the drug experienced brain swelling or brain bleeding, while only 9.3% of those on a placebo had those problems.

Should be interesting to see how much Biogen, Eisai and BioArctic stock will have increased by close.